(Q41328514)

29 September 2017

1 reference

title

Clinical development of a new inactivated hepatitis A vaccine (English)

1 reference

29 September 2017

1 reference

3

S Plotkin

1 reference

29 September 2017

E Vidor

1

1 reference

29 September 2017

B Fritzell

series ordinal

2

1 reference

29 September 2017

publication date

1 November 1996

1 reference

29 September 2017

1 reference

29 September 2017

volume

24

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

447-458

1 reference

Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Studies of prototype live hepatitis A virus vaccines in primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Clinical experience with an inactivated hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Simultaneous vaccination for hepatitis A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Levels of Neutralizing and Binding Antibodies to Hepatitis-A Virus after Onset of Icterus: A Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

A Simple Antigen-Reduction Assay for the Measurement of Neutralizing Antibodies to Hepatitis A Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Effect of Human Immune Serum Globulin on Infectivity of Hepatitis A Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Immunoglobulin prophylaxis for hepatitis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Radioimmunoassay for Detection of Antibody to Hepatitis A Virus: Results of Clinical Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Seroprevalence of hepatitis A antibodies among residents of a centre for people with developmental disabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Multistate outbreak of hepatitis A associated with frozen strawberries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Control of a Hepatitis A Outbreak by Active Immunization of High-Risk Susceptible Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Prevaccination Screening for Citizens of the United States Living Abroad Who Are at Risk for Hepatitis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713047

Vaccination against hepatitis A: control 3 years after the first vaccination

21 January 2018

1 reference

12 December 2020

Prospects for a hepatitis A virus vaccine.

1 reference

12 December 2020

Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions.

1 reference

12 December 2020

Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts

1 reference

12 December 2020

Hepatitis A and health care personnel

1 reference

12 December 2020

Hepatitis A seroprevalence in homosexual and heterosexual men.

1 reference

12 December 2020

Anti-hepatitis A in the general population and in hepatitis A vaccinees using saliva and serum as diagnostic media

1 reference

12 December 2020

Dose response study of an inactivated hepatitis A virus vaccine

1 reference

12 December 2020

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

1 reference

12 December 2020

Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A

1 reference

12 December 2020

Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin

1 reference

12 December 2020

Screening before hepatitis A vaccination

1 reference

12 December 2020

Acute hepatitis A in patients with haemophilia A.

1 reference

12 December 2020

Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation

1 reference

12 December 2020

Hepatitis A vaccination for health care workers

1 reference

12 December 2020

Hepatitis A virus infection among homosexual men.

1 reference

12 December 2020

An Inactivated Hepatitis A Virus Vaccine Prepared from Infected Marmoset Liver

1 reference

12 December 2020

Hepatitis A virus infection. Should susceptible homosexual men be offered immunization

1 reference

12 December 2020

Detection of hepatitis A virus RNA in commercially available factor VIII preparation

1 reference

12 December 2020

Risk of hepatitis A in travellers

1 reference

12 December 2020

Hepatitis A virus infection. No conclusive link to factor VIII.

1 reference

12 December 2020

Persistence of vaccine-induced antibodies for hepatitis A virus

1 reference

12 December 2020

Who should receive hepatitis A vaccine?

1 reference

12 December 2020

Inadequate response to intradermal hepatitis A vaccine

1 reference

12 December 2020

An outbreak of hepatitis A among health care workers: risk factors for transmission

1 reference

12 December 2020

Simultaneous passive and active immunization against hepatitis A

1 reference

12 December 2020

Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers

1 reference

12 December 2020

Should sewage workers and carers for people with learning disabilities be vaccinated for hepatitis A?

1 reference

12 December 2020

Propagation of Human Hepatitis A Virus in Cell Culture in Vitro

1 reference

12 December 2020

Increased risk of hepatitis A among female day-nursery workers in Belgium

1 reference

12 December 2020

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.

1 reference

12 December 2020

Hepatitis A epidemics from utility sewage in Ocoee, Florida

1 reference

12 December 2020

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

1 reference

12 December 2020

Recent advances in hepatitis A vaccine development

1 reference

12 December 2020

Design of hepatitis A vaccines

1 reference

12 December 2020

Inactivated virosome hepatitis A vaccine

1 reference

12 December 2020

Prevalence of hepatitis A virus antibodies in the personnel of a hospital

1 reference

12 December 2020

Genetic, antigenic and biological differences between strains of hepatitis A virus

1 reference

12 December 2020

Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used

1 reference

12 December 2020

Review of the hepatitis A epidemics in hemophiliacs in Europe

1 reference

12 December 2020

Salivary antibody testing in a school outbreak of hepatitis A

1 reference

12 December 2020

An outbreak of hepatitis A during a military field training exercise

1 reference

12 December 2020

Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines

1 reference

12 December 2020

Infectious diseases and injuries in child day care. Opportunities for healthier children

1 reference

12 December 2020

Preparation and immunogenicity of an inactivated hepatitis A vaccine

1 reference

12 December 2020

Passive immunization against hepatitis A

1 reference

12 December 2020

Outbreak of hepatitis A among Italian patients with haemophilia

1 reference

12 December 2020

Inactivated virosome hepatitis A vaccine

1 reference

12 December 2020

Hepatitis A outbreak on a floating restaurant in Florida, 1986

1 reference

12 December 2020

Immunogenicity of a hepatitis A virus vaccine

1 reference

12 December 2020

Persistence of vaccine-induced antibody to hepatitis A virus

1 reference

12 December 2020

Hepatitis A vaccination

1 reference

12 December 2020

Hepatitis in day care centers: epidemiology and prevention.

1 reference

12 December 2020

Prevention of foodborne hepatitis A

1 reference

12 December 2020

Epidemiology and prevention of hepatitis A in travelers

1 reference

12 December 2020

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

12 December 2020

Effect of hepatitis A vaccination schedules on immune response

1 reference

12 December 2020

Community wide outbreak of hepatitis A linked to children in day care centres and with increased transmission in young adult men in Florida 1988-9.

1 reference

12 December 2020

Hepatitis A outbreak involving bread

1 reference

12 December 2020

The immune response to different doses of inactivated hepatitis A vaccine

1 reference

12 December 2020

1 reference

12 December 2020

Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel

1 reference

12 December 2020

Hepatitis A antibodies in attenders of London Travel Clinics: cost-benefit of screening prior to hepatitis A immunisation

1 reference

12 December 2020

Clotting factors and hepatitis A.

1 reference

12 December 2020

Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy

1 reference

12 December 2020

Cost-effectiveness analysis of vaccination against hepatitis A in travellers

1 reference

12 December 2020

Acute hepatitis A in haemophiliacs

1 reference

12 December 2020

Prevalence of serum IgG antibodies to hepatitis A virus in Cambridge haemophiliacs

1 reference

12 December 2020

Immunologic approaches to assessing the response to inactivated hepatitis A vaccine

1 reference

12 December 2020

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study

1 reference

12 December 2020

Hepatitis A immunity in food-handling occupations

1 reference

12 December 2020

Probable post-hepatitis A vaccination encephalopathy

1 reference

12 December 2020

Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response

1 reference

12 December 2020

Hepatitis A as an occupational hazard

1 reference

12 December 2020

Further evaluation of a live hepatitis A vaccine in marmosets.

1 reference

12 December 2020

Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

1 reference

12 December 2020

Prevalence of hepatitis A virus infection among sewage workers in Singapore

1 reference

12 December 2020

Severe hepatitis A despite passive immunisation

1 reference

12 December 2020

Properties of a hepatitis A virus candidate vaccine strain

1 reference

12 December 2020

Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization

1 reference

12 December 2020

Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children

1 reference

12 December 2020

Should British soldiers be vaccinated against hepatitis A? An economic analysis

1 reference

12 December 2020

Clotting factors and hepatitis A

1 reference

12 December 2020

Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants

1 reference

12 December 2020

Infectious liver diseases in three groups of Copenhagen workers: correlation of hepatitis A infection to sewage exposure

1 reference

12 December 2020

Hepatitis A virus infection. Risk to sewage workers unproved

1 reference

12 December 2020

[Strategy of vaccination against hepatitis A]

1 reference

12 December 2020

Intramuscular versus subcutaneous injection for hepatitis B vaccine

1 reference

12 December 2020

Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine

1 reference

12 December 2020

Development of live attenuated hepatitis A vaccine (H2-strain)

1 reference

12 December 2020

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

12 December 2020

Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine

1 reference

12 December 2020

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

12 December 2020

Hepatitis A virus in cell culture. III. Propagation of hepatitis A virus in human embryo kidney cells and human embryo fibroblast strains

1 reference

12 December 2020

An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993.

1 reference

12 December 2020

New findings in live, attenuated hepatitis A vaccine development

1 reference

12 December 2020

Protection against hepatitis A by an inactivated vaccine

1 reference

12 December 2020

The value of immunization against hepatitis A

1 reference

12 December 2020

Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients

1 reference

12 December 2020

Standardization of Poliovirus Neutralizing Antibody Tests

1 reference

12 December 2020

Production, quality control and characterization of an inactivated hepatitis A vaccine

1 reference

12 December 2020

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

12 December 2020

Virosomes as carriers for combined vaccines

1 reference

12 December 2020

Interruption of an outbreak of hepatitis A in two villages by vaccination

1 reference

12 December 2020

Hepatitis A Outbreak in a Neonatal Intensive Care Unit: Risk Factors for Transmission and Evidence of Prolonged Viral Excretion among Preterm Infants

1 reference

12 December 2020

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

1 reference

12 December 2020

Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine

1 reference

12 December 2020

Virology of the hepatitis A epidemic in Italy

1 reference

12 December 2020

Propagation of human hepatitis A virus in a hepatoma cell line

1 reference

12 December 2020

Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men

1 reference

12 December 2020

Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine

1 reference

12 December 2020

Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A

1 reference

12 December 2020

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

1 reference

12 December 2020

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

1 reference

12 December 2020

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

12 December 2020

Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers

1 reference

12 December 2020

Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin

1 reference

12 December 2020

Sensitive assays for hepatitis A antibodies

1 reference

12 December 2020

Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit

1 reference

12 December 2020

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01713047

1 reference

29 September 2017

1 reference